메뉴 건너뛰기




Volumn 38, Issue 5, 2012, Pages 958-966

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia

Author keywords

cognition; glycine; glycine transport inhibitors; negative symptoms; neurophysiology; NMDA receptors; schizophrenia

Indexed keywords

ACETYLCYSTEINE; AMIDE; BITOPERTIN; BUNGAROTOXIN RECEPTOR; CYCLOSERINE; DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; GLUTATHIONE; GLYCINE; GLYCINE TRANSPORT INHIBITOR; GLYCYLDODECYLAMIDE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PHENCYCLIDINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

EID: 84866674097     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs069     Document Type: Article
Times cited : (247)

References (77)
  • 1
    • 0023082787 scopus 로고
    • Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia
    • Javitt DC. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry. 1987;9:12-35.
    • (1987) Hillside J Clin Psychiatry , vol.9 , pp. 12-35
    • Javitt, D.C.1
  • 2
    • 0025952455 scopus 로고
    • Recent advances in the phencyclidine model of schizophrenia
    • Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
    • (1991) Am J Psychiatry , vol.148 , pp. 1301-1308
    • Javitt, D.C.1    Zukin, S.R.2
  • 3
    • 0028850552 scopus 로고
    • Glutamate receptor dysfunction and schizophrenia
    • Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 998-1007
    • Olney, J.W.1    Farber, N.B.2
  • 4
    • 0030044715 scopus 로고    scopus 로고
    • The glutamatergic dysfunction hypothesis for schizophrenia
    • Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3:241-253.
    • (1996) Harv Rev Psychiatry , vol.3 , pp. 241-253
    • Coyle, J.T.1
  • 5
    • 65349120160 scopus 로고    scopus 로고
    • The dopamine hypothesis of schizophrenia: Version III-the final common pathway
    • Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull. 2009;35:549-562.
    • (2009) Schizophr Bull , vol.35 , pp. 549-562
    • Howes, O.D.1    Kapur, S.2
  • 7
    • 78650883892 scopus 로고    scopus 로고
    • Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride
    • Slifstein M, Suckow RF, Javitch JA, Cooper T, Lieberman J, Abi-Dargham A. Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride. J Cereb Blood Flow Metab. 2011;31:293-304.
    • (2011) J Cereb Blood Flow Metab , vol.31 , pp. 293-304
    • Slifstein, M.1    Suckow, R.F.2    Javitch, J.A.3    Cooper, T.4    Lieberman, J.5    Abi-Dargham, A.6
  • 8
    • 77956648156 scopus 로고    scopus 로고
    • N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
    • Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 2010;83:108-121.
    • (2010) Brain Res Bull , vol.83 , pp. 108-121
    • Kantrowitz, J.T.1    Javitt, D.C.2
  • 9
    • 9744231378 scopus 로고    scopus 로고
    • Neurodevelopment, neuroplasticity, and new genes for schizophrenia
    • Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res. 2005;147:319-345.
    • (2005) Prog Brain Res , vol.147 , pp. 319-345
    • Arnold, S.E.1    Talbot, K.2    Hahn, C.G.3
  • 10
    • 78650006680 scopus 로고    scopus 로고
    • Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance
    • Karlsgodt KH, Robleto K, Trantham-Davidson H, et al. Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry. 2011;69:28-34.
    • (2011) Biol Psychiatry , vol.69 , pp. 28-34
    • Karlsgodt, K.H.1    Robleto, K.2    Trantham-Davidson, H.3
  • 11
    • 46249104490 scopus 로고    scopus 로고
    • Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database
    • Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827-834.
    • (2008) Nat Genet , vol.40 , pp. 827-834
    • Allen, N.C.1    Bagade, S.2    McQueen, M.B.3
  • 12
    • 33846194535 scopus 로고    scopus 로고
    • Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis
    • Li D, He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet Med. 2007;9:4-8.
    • (2007) Genet Med , vol.9 , pp. 4-8
    • Li, D.1    He, L.2
  • 13
    • 34447555923 scopus 로고    scopus 로고
    • Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia
    • Shinkai T, De Luca V, Hwang R, et al. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med. 2007;9:169-177.
    • (2007) Neuromolecular Med , vol.9 , pp. 169-177
    • Shinkai, T.1    De Luca, V.2    Hwang, R.3
  • 14
    • 34247863795 scopus 로고    scopus 로고
    • G72/G30 genes and schizophrenia: A systematic meta-analysis of association studies
    • Li D, He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics. 2007;175:917-922.
    • (2007) Genetics , vol.175 , pp. 917-922
    • Li, D.1    He, L.2
  • 15
    • 81355138985 scopus 로고    scopus 로고
    • Behavioral phenotyping of glutathione-deficient mice: Relevance to schizophrenia and bipolar disorder
    • Kulak A, Cuenod M, Do KQ. Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder. Behav Brain Res. 2012;226:563-570.
    • (2012) Behav Brain Res , vol.226 , pp. 563-570
    • Kulak, A.1    Cuenod, M.2    Do, K.Q.3
  • 16
    • 33745912772 scopus 로고    scopus 로고
    • Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
    • Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 2006;12:824-828.
    • (2006) Nat Med , vol.12 , pp. 824-828
    • Hahn, C.G.1    Wang, H.Y.2    Cho, D.S.3
  • 17
    • 77649197534 scopus 로고    scopus 로고
    • Increased synaptic dopamine function in associative regions of the striatum in schizophrenia
    • Kegeles LS, Abi-Dargham A, Frankle WG, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010;67:231-239.
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 231-239
    • Kegeles, L.S.1    Abi-Dargham, A.2    Frankle, W.G.3
  • 18
    • 58149489347 scopus 로고    scopus 로고
    • Elevated striatal dopamine function linked to prodromal signs of schizophrenia
    • Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13-20.
    • (2009) Arch Gen Psychiatry , vol.66 , pp. 13-20
    • Howes, O.D.1    Montgomery, A.J.2    Asselin, M.C.3
  • 19
    • 26844447871 scopus 로고    scopus 로고
    • Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man
    • Aalto S, Ihalainen J, Hirvonen J, et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl). 2005;182:375-383.
    • (2005) Psychopharmacology (Berl) , vol.182 , pp. 375-383
    • Aalto, S.1    Ihalainen, J.2    Hirvonen, J.3
  • 20
    • 0037209259 scopus 로고    scopus 로고
    • Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release
    • Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology. 2003;28:34-44.
    • (2003) Neuropsychopharmacology , vol.28 , pp. 34-44
    • Balla, A.1    Sershen, H.2    Serra, M.3    Koneru, R.4    Javitt, D.C.5
  • 21
    • 0842286593 scopus 로고    scopus 로고
    • Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists
    • Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology. 2004;29:300-307.
    • (2004) Neuropsychopharmacology , vol.29 , pp. 300-307
    • Javitt, D.C.1    Balla, A.2    Burch, S.3    Suckow, R.4    Xie, S.5    Sershen, H.6
  • 22
    • 36849089633 scopus 로고    scopus 로고
    • Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site- mediated dopaminergic dysregulation and dopamine transporter function
    • Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochem Int. 2008;52:119-129.
    • (2008) Neurochem Int , vol.52 , pp. 119-129
    • Sershen, H.1    Balla, A.2    Aspromonte, J.M.3    Xie, S.4    Cooper, T.B.5    Javitt, D.C.6
  • 23
    • 84870717591 scopus 로고    scopus 로고
    • Effects of novel high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia
    • [published online ahead of print May 09,2012] doi:10.1016/j. euroneuro.2012.03.006
    • Balla A, Schneider S, Sershen H, Javitt DC. Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia [published online ahead of print May 09, 2012]. Eur Neuropsychopharmacol. doi:10.1016/j. euroneuro.2012.03.006.
    • Eur Neuropsychopharmacol
    • Balla, A.1    Schneider, S.2    Sershen, H.3    Javitt, D.C.4
  • 24
    • 69849109615 scopus 로고    scopus 로고
    • Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia
    • Schobel SA, Kelly MA, Corcoran CM, et al. Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr Res. 2009;114:110-118.
    • (2009) Schizophr Res , vol.114 , pp. 110-118
    • Schobel, S.A.1    Kelly, M.A.2    Corcoran, C.M.3
  • 25
    • 73949124536 scopus 로고    scopus 로고
    • Sensory processing in schizophrenia: Neither simple nor intact
    • Javitt DC. Sensory processing in schizophrenia: neither simple nor intact. Schizophr Bull. 2009;35:1059-1064.
    • (2009) Schizophr Bull , vol.35 , pp. 1059-1064
    • Javitt, D.C.1
  • 26
    • 0029859204 scopus 로고    scopus 로고
    • Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia
    • Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA. 1996;93:11962-11967.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 11962-11967
    • Javitt, D.C.1    Steinschneider, M.2    Schroeder, C.E.3    Arezzo, J.C.4
  • 27
    • 80053221118 scopus 로고    scopus 로고
    • Translating glutamate: From pathophysiology to treatment
    • Javitt DC, Schoepp D, Kalivas PW, et al.Translating glutamate: from pathophysiology to treatment. Sci Transl Med. 2011;3:102mr102.
    • (2011) Sci Transl Med , vol.3 , pp. 102-102
    • Javitt, D.C.1    Schoepp, D.2    Kalivas, P.W.3
  • 28
    • 0037209132 scopus 로고    scopus 로고
    • Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficits in schizophrenia
    • Umbricht D, Vollenweider FX, Schmid L, et al. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology. 2003;28:170-181.
    • (2003) Neuropsychopharmacology , vol.28 , pp. 170-181
    • Umbricht, D.1    Vollenweider, F.X.2    Schmid, L.3
  • 29
    • 46149109833 scopus 로고    scopus 로고
    • Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
    • Heekeren K, Daumann J, Neukirch A, et al. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl). 2008;199:77-88.
    • (2008) Psychopharmacology (Berl) , vol.199 , pp. 77-88
    • Heekeren, K.1    Daumann, J.2    Neukirch, A.3
  • 32
    • 77952554458 scopus 로고    scopus 로고
    • Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats
    • Tikhonravov D, Neuvonen T, Pertovaara A, et al. Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats. Neuroscience. 2010;167:1175-1182.
    • (2010) Neuroscience , vol.167 , pp. 1175-1182
    • Tikhonravov, D.1    Neuvonen, T.2    Pertovaara, A.3
  • 33
    • 0036501435 scopus 로고    scopus 로고
    • Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
    • Umbricht D, Koller R, Vollenweider FX, Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry. 2002;51:400-406.
    • (2002) Biol Psychiatry , vol.51 , pp. 400-406
    • Umbricht, D.1    Koller, R.2    Vollenweider, F.X.3    Schmid, L.4
  • 34
    • 79955481536 scopus 로고    scopus 로고
    • Prediction of psychosis by mismatch negativity
    • Bodatsch M, Ruhrmann S, Wagner M, et al. Prediction of psychosis by mismatch negativity. Biol Psychiatry. 2011;69:959-966.
    • (2011) Biol Psychiatry , vol.69 , pp. 959-966
    • Bodatsch, M.1    Ruhrmann, S.2    Wagner, M.3
  • 35
    • 75749085177 scopus 로고    scopus 로고
    • Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine
    • Hong LE, Summerfelt A, Buchanan RW, et al. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology. 2010;35:632-640.
    • (2010) Neuropsychopharmacology , vol.35 , pp. 632-640
    • Hong, L.E.1    Summerfelt, A.2    Buchanan, R.W.3
  • 36
    • 69249209812 scopus 로고    scopus 로고
    • Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate
    • Bickel S, Javitt DC. Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res. 2009;204:352-362.
    • (2009) Behav Brain Res , vol.204 , pp. 352-362
    • Bickel, S.1    Javitt, D.C.2
  • 37
    • 18244366892 scopus 로고    scopus 로고
    • Early-stage visual processing and cortical amplification deficits in schizophrenia
    • Butler PD, Zemon V, Schechter I, et al. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry. 2005;62:495-504.
    • (2005) Arch Gen Psychiatry , vol.62 , pp. 495-504
    • Butler, P.D.1    Zemon, V.2    Schechter, I.3
  • 38
    • 67650130341 scopus 로고    scopus 로고
    • When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia
    • Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol. 2009;5:249-275.
    • (2009) Annu Rev Clin Psychol , vol.5 , pp. 249-275
    • Javitt, D.C.1
  • 39
    • 84861562756 scopus 로고    scopus 로고
    • Consequences of magnocellular dysfunction on processing attended information in schizophrenia
    • Martínez A, Hillyard SA, Bickel S, Dias EC, Butler PD, Javitt DC. Consequences of magnocellular dysfunction on processing attended information in schizophrenia. Cereb Cortex. 2012;22:1282-1293.
    • (2012) Cereb Cortex , vol.22 , pp. 1282-1293
    • Martínez, A.1    Hillyard, S.A.2    Bickel, S.3    Dias, E.C.4    Butler, P.D.5    Javitt, D.C.6
  • 40
    • 77955878074 scopus 로고    scopus 로고
    • Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: An integrated neuroimaging study
    • Sehatpour P, Dias EC, Butler PD, et al. Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. Arch Gen Psychiatry. 2010;67:772-782.
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 772-782
    • Sehatpour, P.1    Dias, E.C.2    Butler, P.D.3
  • 41
    • 79960321156 scopus 로고    scopus 로고
    • Early sensory contributions to contextual encoding deficits in schizophrenia
    • Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early sensory contributions to contextual encoding deficits in schizophrenia. Arch Gen Psychiatry. 2011;68:654-664.
    • (2011) Arch Gen Psychiatry , vol.68 , pp. 654-664
    • Dias, E.C.1    Butler, P.D.2    Hoptman, M.J.3    Javitt, D.C.4
  • 42
    • 84871845819 scopus 로고    scopus 로고
    • Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder
    • [published online ahead of print July 05 2011] doi:10.1093/schbul/sbr060
    • Kantrowitz JT, Leitman DI, Lehrfeld JM, et al. Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder [published online ahead of print July 05, 2011]. Schizophr Bull. doi:10.1093/schbul/sbr060.
    • Schizophr Bull
    • Kantrowitz, J.T.1    Leitman, D.I.2    Lehrfeld, J.M.3
  • 43
    • 73949149661 scopus 로고    scopus 로고
    • Sensory contributions to impaired emotion processing in schizophrenia
    • Butler PD, Abeles IY, Weiskopf NG, et al. Sensory contributions to impaired emotion processing in schizophrenia. Schizophr Bull. 2009;35:1095-1107.
    • (2009) Schizophr Bull , vol.35 , pp. 1095-1107
    • Butler, P.D.1    Abeles, I.Y.2    Weiskopf, N.G.3
  • 44
    • 67349149048 scopus 로고    scopus 로고
    • Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia
    • Norton D, McBain R, Holt DJ, Ongur D, Chen Y. Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophrenia. Biol Psychiatry. 2009;65:1094-1098.
    • (2009) Biol Psychiatry , vol.65 , pp. 1094-1098
    • Norton, D.1    McBain, R.2    Holt, D.J.3    Ongur, D.4    Chen, Y.5
  • 45
    • 80051799656 scopus 로고    scopus 로고
    • Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task
    • Musso F, Brinkmeyer J, Ecker D, et al. Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task. Neuroimage. 2011;58:508-525.
    • (2011) Neuroimage , vol.58 , pp. 508-525
    • Musso, F.1    Brinkmeyer, J.2    Ecker, D.3
  • 46
    • 77953206219 scopus 로고    scopus 로고
    • Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: Implications for pathophysiology of executive dysfunction in schizophrenia
    • Wylie GR, Clark EA, Butler PD, Javitt DC. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia. Schizophr Bull. 2010;36:585-594.
    • (2010) Schizophr Bull , vol.36 , pp. 585-594
    • Wylie, G.R.1    Clark, E.A.2    Butler, P.D.3    Javitt, D.C.4
  • 47
    • 34247568367 scopus 로고    scopus 로고
    • Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine
    • Linn GS, O'Keeffe RT, Lifshitz K, Schroeder C, Javitt DC. Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine. Psychopharmacology (Berl). 2007;192:27-38.
    • (2007) Psychopharmacology (Berl) , vol.192 , pp. 27-38
    • Linn, G.S.1    O'Keeffe, R.T.2    Lifshitz, K.3    Schroeder, C.4    Javitt, D.C.5
  • 48
    • 79952454124 scopus 로고    scopus 로고
    • Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis
    • Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2011;231:86-91.
    • (2011) J Neuroimmunol , vol.231 , pp. 86-91
    • Wandinger, K.P.1    Saschenbrecker, S.2    Stoecker, W.3    Dalmau, J.4
  • 49
    • 84856104234 scopus 로고    scopus 로고
    • Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
    • Powell SB, Sejnowski TJ, Behrens MM. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology. 2012;62:1322-1331.
    • (2012) Neuropharmacology , vol.62 , pp. 1322-1331
    • Powell, S.B.1    Sejnowski, T.J.2    Behrens, M.M.3
  • 50
    • 0023091647 scopus 로고
    • Glycine potentiates the NMDA response in cultured mouse brain neurons
    • Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987;325:529-531.
    • (1987) Nature , vol.325 , pp. 529-531
    • Johnson, J.W.1    Ascher, P.2
  • 51
    • 0028988978 scopus 로고
    • D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release
    • Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA. 1995;92:3948-3952.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 3948-3952
    • Schell, M.J.1    Molliver, M.E.2    Snyder, S.H.3
  • 52
    • 48749112603 scopus 로고    scopus 로고
    • N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial
    • Berk M, Copolov D, Dean O, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361-368.
    • (2008) Biol Psychiatry , vol.64 , pp. 361-368
    • Berk, M.1    Copolov, D.2    Dean, O.3
  • 53
    • 36849071470 scopus 로고    scopus 로고
    • Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
    • Lane HY, Liu YC, Huang CL, et al. Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol Psychiatry. 2008; 63:9-12.
    • (2008) Biol Psychiatry , vol.63 , pp. 9-12
    • Lane, H.Y.1    Liu, Y.C.2    Huang, C.L.3
  • 54
    • 67649989298 scopus 로고    scopus 로고
    • Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
    • Javitt DC. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Curr Opin Drug Discov Devel. 2009;12:468-478.
    • (2009) Curr Opin Drug Discov Devel , vol.12 , pp. 468-478
    • Javitt, D.C.1
  • 55
    • 9244243064 scopus 로고    scopus 로고
    • Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis
    • Tuominen HJ, Tiihonen J, Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2005;72:225-234.
    • (2005) Schizophr Res , vol.72 , pp. 225-234
    • Tuominen, H.J.1    Tiihonen, J.2    Wahlbeck, K.3
  • 56
    • 77949447469 scopus 로고    scopus 로고
    • Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
    • Tsai GE, Lin PY. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr Pharm Des. 2010;16:522-537.
    • (2010) Curr Pharm des , vol.16 , pp. 522-537
    • Tsai, G.E.1    Lin, P.Y.2
  • 57
    • 80052996482 scopus 로고    scopus 로고
    • Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia
    • Singh SP, Singh V. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs. 2011;25:859-885.
    • (2011) CNS Drugs , vol.25 , pp. 859-885
    • Singh, S.P.1    Singh, V.2
  • 58
    • 84861996250 scopus 로고    scopus 로고
    • D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease
    • Gelfin E, Kaufman Y, Korn-Lubetzki I, et al. D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease. Int J Neuropsychopharmacol. 2011:1-7.
    • (2011) Int J Neuropsychopharmacol , pp. 1-7
    • Gelfin, E.1    Kaufman, Y.2    Korn-Lubetzki, I.3
  • 59
    • 0030811293 scopus 로고    scopus 로고
    • Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide
    • Javitt DC, Sershen H, Hashim A, Lajtha A. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology. 1997;17:202-204.
    • (1997) Neuropsychopharmacology , vol.17 , pp. 202-204
    • Javitt, D.C.1    Sershen, H.2    Hashim, A.3    Lajtha, A.4
  • 60
    • 0033558578 scopus 로고    scopus 로고
    • Bennett research award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
    • Javitt DC, Balla A, Sershen H, Lajtha A. A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Biol Psychiatry. 1999;45:668-679.
    • (1999) Biol Psychiatry , vol.45 , pp. 668-679
    • Javitt, D.C.1    Balla, A.2    Sershen, H.3    Lajtha, A.A.E.4
  • 61
    • 0034015991 scopus 로고    scopus 로고
    • Inhibition of striatal dopamine release by glycine and glycyldodecylamide
    • Javitt DC, Sershen H, Hashim A, Lajtha A. Inhibition of striatal dopamine release by glycine and glycyldodecylamide. Brain Res Bull. 2000;52:213-216.
    • (2000) Brain Res Bull , vol.52 , pp. 213-216
    • Javitt, D.C.1    Sershen, H.2    Hashim, A.3    Lajtha, A.4
  • 63
    • 77953771657 scopus 로고    scopus 로고
    • Selective GlyT1 inhibitors: Discovery of [4-(3-fluoro-5- trifluoromethylpyridin-2-yl) piperazin-1-yl][5-methanesulfon yl-2-((S)-2 2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia
    • Pinard E, Alanine A, Alberati D, et al. Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl) piperazin-1-yl][5- methanesulfon yl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia. J Med Chem. 2010;53:4603-4614.
    • (2010) J Med Chem , vol.53 , pp. 4603-4614
    • Pinard, E.1    Alanine, A.2    Alberati, D.3
  • 64
    • 79955730287 scopus 로고    scopus 로고
    • Glycine transporter type 1 (GLYT1) inhibitor RG1678: Positive results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia
    • Umbricht D, Yoo K, Youssef E, et al. Glycine transporter type 1 (GLYT1) inhibitor RG1678: positive results of the proof-of-concept study for the treatment of negative symptoms in schizophrenia. Neuropsychopharmacol. 2010;35:s320-321.
    • (2010) Neuropsychopharmacol , vol.35
    • Umbricht, D.1    Yoo, K.2    Youssef, E.3
  • 65
    • 67349116852 scopus 로고    scopus 로고
    • Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine
    • Hashimoto K, Fujita Y, Horio M, et al. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry. 2009;65:1103-1106.
    • (2009) Biol Psychiatry , vol.65 , pp. 1103-1106
    • Hashimoto, K.1    Fujita, Y.2    Horio, M.3
  • 66
    • 0037150760 scopus 로고    scopus 로고
    • A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes
    • Javitt DC, Balla A, Sershen H. A novel alanine-insensitive D-serine transporter in rat brain synaptosomal membranes. Brain Res. 2002;941:146-149.
    • (2002) Brain Res , vol.941 , pp. 146-149
    • Javitt, D.C.1    Balla, A.2    Sershen, H.3
  • 67
    • 47249165587 scopus 로고    scopus 로고
    • Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
    • Lavoie S, Murray MM, Deppen P, et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology. 2008;33:2187-2199.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 2187-2199
    • Lavoie, S.1    Murray, M.M.2    Deppen, P.3
  • 68
    • 36848999415 scopus 로고    scopus 로고
    • Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia
    • Roffman JL, Weiss AP, Purcell S, et al. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry. 2008;63:42-48.
    • (2008) Biol Psychiatry , vol.63 , pp. 42-48
    • Roffman, J.L.1    Weiss, A.P.2    Purcell, S.3
  • 69
    • 77749242786 scopus 로고    scopus 로고
    • Cortical kynurenine pathway metabolism: A novel target for cognitive enhancement in Schizophrenia
    • Wonodi I Schwarcz R. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. Schizophr Bull. 2010;36:211-218.
    • (2010) Schizophr Bull , vol.36 , pp. 211-218
    • Wonodi, I.1    Schwarcz, R.2
  • 70
    • 52449083063 scopus 로고    scopus 로고
    • [11C] CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: A PET study in conscious monkeys
    • Hashimoto K, Nishiyama S, Ohba H, et al. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys. PLoS ONE. 2008;3:e3231.
    • (2008) PLoS ONE , vol.3
    • Hashimoto, K.1    Nishiyama, S.2    Ohba, H.3
  • 71
    • 63049128572 scopus 로고    scopus 로고
    • GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum
    • Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology. 2009;56:915-921.
    • (2009) Neuropharmacology , vol.56 , pp. 915-921
    • Balla, A.1    Nattini, M.E.2    Sershen, H.3    Lajtha, A.4    Dunlop, D.S.5    Javitt, D.C.6
  • 72
    • 77954145611 scopus 로고    scopus 로고
    • The importance of a good night's sleep: An open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia
    • Kantrowitz JT, Oakman E, Bickel S, et al. The importance of a good night's sleep: an open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia. Schizophr Res. 2010;120:225-226.
    • (2010) Schizophr Res , vol.120 , pp. 225-226
    • Kantrowitz, J.T.1    Oakman, E.2    Bickel, S.3
  • 73
    • 34047185321 scopus 로고    scopus 로고
    • The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents
    • Leitman DI, Hoptman MJ, Foxe JJ, et al. The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. Am J Psychiatry. 2007;164:474-482.
    • (2007) Am J Psychiatry , vol.164 , pp. 474-482
    • Leitman, D.I.1    Hoptman, M.J.2    Foxe, J.J.3
  • 75
    • 1442333154 scopus 로고    scopus 로고
    • High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
    • Heresco-Levy U. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatr. 2004;55:165-171.
    • (2004) Biol Psychiatr , vol.55 , pp. 165-171
    • Heresco-Levy, U.1
  • 76
    • 15444377601 scopus 로고    scopus 로고
    • D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
    • Heresco-Levy U, Javitt DC, Ebstein R, et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry. 2005;57:577-585.
    • (2005) Biol Psychiatry , vol.57 , pp. 577-585
    • Heresco-Levy, U.1    Javitt, D.C.2    Ebstein, R.3
  • 77
    • 77955056793 scopus 로고    scopus 로고
    • High dose D-serine in the treatment of schizophrenia
    • Kantrowitz JT, Malhotra AK, Cornblatt B, et al. High dose D-serine in the treatment of schizophrenia. Schizophr Res. 2010;121:125-130.
    • (2010) Schizophr Res , vol.121 , pp. 125-130
    • Kantrowitz, J.T.1    Malhotra, A.K.2    Cornblatt, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.